Homocysteinethiolactone and Paraoxonase: Novel markers of diabetic retinopathy

Homocysteine Thiolactone Induces Cardiac Dysfunction: Role of Oxidative Stress

(2010) R H Mendes et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Diabetic Nephropathy in the Elderly

(2009) Anthony J. Joseph et al.   CLINICS IN GERIATRIC MEDICINE

Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus

(2009) Kazuo Sonoki et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

A Common Mutation in Paraoxonase-2 Results in Impaired Lactonase Activity

(2009) David A. Stoltz et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Plasma and Vitreous Homocysteine Concentrations in Patients With Proliferative Diabetic Retinopathy

(2009) ORHAN AYDEMIR et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Plasma homocysteine thiolactone associated with risk of macrovasculopathy in Chinese patients with type 2 diabetes mellitus

(2008) Weijun Gu et al.   ADVANCES IN THERAPY

Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection

(2008) Markus Thiersch et al.   BMC GENOMICS

Relationship between thiolactonase activity and hyperhomocysteinemia according to MTHFR gene polymorphism in Tunisian Behçet's disease patients

(2007) Nadia Koubaa et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE